Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CardioPhase® hsCRP

K-Number: K232624 · 2023-11-27

Decision Date2023-11-27
Product CodeDCN
Advisory CommitteeIM
DecisionSubstantially Equivalent

Device Summary

CardioPhase® hsCRP is a medical device manufactured by Siemens Healthcare Diagnostic Products GmbH. It received FDA 510(k) clearance on 2023-11-27 under approval number K232624. The device is classified under product code DCN. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CardioPhase® hsCRP?

CardioPhase® hsCRP is a medical device that received FDA 510(k) clearance on 2023-11-27. It is manufactured by Siemens Healthcare Diagnostic Products GmbH. The 510(k) number is K232624.

When was CardioPhase® hsCRP approved by the FDA?

CardioPhase® hsCRP received FDA 510(k) clearance on 2023-11-27, under approval number K232624.

What company makes CardioPhase® hsCRP?

CardioPhase® hsCRP is manufactured by Siemens Healthcare Diagnostic Products GmbH.

What is the FDA product code for CardioPhase® hsCRP?

The FDA product code for CardioPhase® hsCRP is DCN.

Other Devices by Siemens Healthcare Diagnostic Products GmbH

Related Devices (Code: DCN)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.